D-Wave Quantum (NYSE: QBTS) has delivered a roughly 12x return over the past three years, setting an extremely high bar for any further upside from current levels.

The stock scored just 1 out of 6 on value checks, signaling that it does not screen as a clear bargain across broader valuation metrics.

D-Wave trades at a price-to-book ratio of approximately 6.4x, which is roughly double the Software industry average of 3.1x, though slightly below the peer group average of 7.1x.

The elevated P/B multiple is particularly significant because the company is still working toward consistent cash flows and earnings, making the balance sheet a more relevant valuation anchor than a price-to-earnings ratio.

Recent enterprise partnerships with AT&T and Nasdaq Verafin have supported high growth expectations, though execution risk around converting those projects into durable cash flows remains a concern for investors.

Research progress on a high-fidelity two-qubit gate has added to market enthusiasm, but the central question is how much of that progress is already reflected in the current share price.

D-Wave Quantum delivered 13.0% returns over the last year, a result that investors will now be weighing against the company’s premium valuation relative to the broader Software sector.

Despite the positive enterprise announcements, the market appears to already be assigning significant value to D-Wave’s quantum computing assets and partnerships, even though the accounting equity base remains relatively modest.

One top community narrative on the stock argued that D-Wave is “52% undervalued,” citing “a massive $550 million acquisition, a record-breaking month of sales, and a newly fortified balance sheet,” adding that “D-Wave has moved the ‘Quantum Era’ off the whiteboards and into the executive boardroom.”

The core debate for investors is whether D-Wave can translate its technology milestones and enterprise relationships into a reliable cash flow profile that justifies its premium valuation multiple.

With broader valuation checks screening weak, the current price leaves limited room for execution missteps or slower-than-expected commercial adoption across its enterprise customer base.

Any meaningful valuation reset could occur if the company’s commercial progress takes longer than optimistic shareholders currently anticipate, particularly given the stock’s extraordinary run over the past three years.